-
1
-
-
0032993716
-
Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders
-
Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 1999;60(Suppl 2):77-84.
-
(1999)
J. Clin. Psychiatry
, vol.60
, Issue.SUPPL. 2
, pp. 77-84
-
-
Baldessarini, R.J.1
Tondo, L.2
Hennen, J.3
-
2
-
-
0031846536
-
Lithium treatment and risk of suicidal behavior in bipolar disorder patients
-
Tondo L, Baldessarini RJ, Hennen J, Floris G, Silvetti F, Tohen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998;59:405-414.
-
(1998)
J. Clin. Psychiatry
, vol.59
, pp. 405-414
-
-
Tondo, L.1
Baldessarini, R.J.2
Hennen, J.3
Floris, G.4
Silvetti, F.5
Tohen, M.6
-
3
-
-
0026726290
-
The effect of longterm lithium treatment on the mortality of patients with manicdepressive and schizoaffective illness
-
Muller-Oerlinghausen B, Ahrens B, Grof E, et al. The effect of longterm lithium treatment on the mortality of patients with manicdepressive and schizoaffective illness. Acta Psychiatr Scand 1992;86:218-222.
-
(1992)
Acta Psychiatr. Scand.
, vol.86
, pp. 218-222
-
-
Muller-Oerlinghausen, B.1
Ahrens, B.2
Grof, E.3
-
4
-
-
0026731112
-
Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication
-
Muller-Oerlinghausen B, Muser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992;25:261-269.
-
(1992)
J. Affect. Disord.
, vol.25
, pp. 261-269
-
-
Muller-Oerlinghausen, B.1
Muser-Causemann, B.2
Volk, J.3
-
5
-
-
0028893706
-
Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis
-
Ahrens B, Muller-Oerlinghausen B, Schou M, et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 1995;33:67-75.
-
(1995)
J. Affect. Disord.
, vol.33
, pp. 67-75
-
-
Ahrens, B.1
Muller-Oerlinghausen, B.2
Schou, M.3
-
6
-
-
0029050935
-
Extended survival of patients on long-term lithium treatment
-
Ahrens B, Grof P, Moller HJ, Muller-Oerlinghausen B, Wolf T. Extended survival of patients on long-term lithium treatment. Can J Psychiatry 1995;40:241-246.
-
(1995)
Can. J. Psychiatry
, vol.40
, pp. 241-246
-
-
Ahrens, B.1
Grof, P.2
Moller, H.J.3
Muller-Oerlinghausen, B.4
Wolf, T.5
-
7
-
-
0033587742
-
Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons
-
Chalecka-Franaszek E, Chuang DM. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999;96:8745-8750.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 8745-8750
-
-
Chalecka-Franaszek, E.1
Chuang, D.M.2
-
8
-
-
0031870871
-
Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine
-
Nonaka S, Katsube N, Chuang DM. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 1998;286:539-547.
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.286
, pp. 539-547
-
-
Nonaka, S.1
Katsube, N.2
Chuang, D.M.3
-
9
-
-
0032478088
-
Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx
-
Nonaka S, Hough CJ, Chuang DM. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998;95:2642-2647.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 2642-2647
-
-
Nonaka, S.1
Hough, C.J.2
Chuang, D.M.3
-
10
-
-
0036116367
-
Neuroprotective effects of lithium in cultured cells and animal models of diseases
-
Chuang DM, Chen RW, Chalecka-Franaszek E, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 2002;4:129-136.
-
(2002)
Bipolar. Disord.
, vol.4
, pp. 129-136
-
-
Chuang, D.M.1
Chen, R.W.2
Chalecka-Franaszek, E.3
-
11
-
-
0033525538
-
Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity
-
Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999;274:6039-6042.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 6039-6042
-
-
Chen, R.W.1
Chuang, D.M.2
-
12
-
-
0034795827
-
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain
-
Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 2001;158:100-106.
-
(2001)
Psychopharmacology (Berl)
, vol.158
, pp. 100-106
-
-
Fukumoto, T.1
Morinobu, S.2
Okamoto, Y.3
Kagaya, A.4
Yamawaki, S.5
-
13
-
-
0032557889
-
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
-
Nonaka S, Chuang DM. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 1998;9:2081-2084.
-
(1998)
Neuroreport
, vol.9
, pp. 2081-2084
-
-
Nonaka, S.1
Chuang, D.M.2
-
14
-
-
0035960005
-
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease
-
Wei H, Qin Z, Senatorov VV, et al. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 2001;106:603-612.
-
(2001)
Neuroscience
, vol.106
, pp. 603-612
-
-
Wei, H.1
Qin, Z.2
Senatorov, V.V.3
-
15
-
-
18744435263
-
Lithium increases Nacetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects?
-
Moore GJ, Bebchuk JM, Hasanat K, et al. Lithium increases Nacetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000;48:1-8.
-
(2000)
Biol. Psychiatry
, vol.48
, pp. 1-8
-
-
Moore, G.J.1
Bebchuk, J.M.2
Hasanat, K.3
-
16
-
-
0034619037
-
Lithium-induced increase in human brain grey matter
-
Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet 2000;356:1241-1242.
-
(2000)
Lancet
, vol.356
, pp. 1241-1242
-
-
Moore, G.J.1
Bebchuk, J.M.2
Wilds, I.B.3
Chen, G.4
Manji, H.K.5
-
17
-
-
0035878181
-
Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium
-
Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001;55:651-659.
-
(2001)
Brain Res. Bull.
, vol.55
, pp. 651-659
-
-
Knable, M.B.1
Torrey, E.F.2
Webster, M.J.3
Bartko, J.J.4
-
18
-
-
0015751682
-
Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report
-
Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A. Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report. Folia Psychiatr Neurol Jpn 1973;27:283-297.
-
(1973)
Folia Psychiatr. Neurol. Jpn.
, vol.27
, pp. 283-297
-
-
Okuma, T.1
Kishimoto, A.2
Inoue, K.3
Matsumoto, H.4
Ogura, A.5
-
19
-
-
0011571986
-
Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic-depressive psychosis
-
Okuma T, Kishimoto A, Inoue K. Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic-depressive psychosis. Seishin Igaku 1975;17:617-630.
-
(1975)
Seishin Igaku
, vol.17
, pp. 617-630
-
-
Okuma, T.1
Kishimoto, A.2
Inoue, K.3
-
20
-
-
0020082544
-
Carbamazepine treatment of selected affectively disordered inpatients
-
Folks DG, King LD, Dowdy SB, et al. Carbamazepine treatment of selected affectively disordered inpatients. Am J Psychiatry 1982;139:115-117.
-
(1982)
Am. J. Psychiatry
, vol.139
, pp. 115-117
-
-
Folks, D.G.1
King, L.D.2
Dowdy, S.B.3
-
21
-
-
0021367113
-
The treatment of chronic depression. An illustrative case
-
Barker WA, Eccleston D. The treatment of chronic depression. An illustrative case. Br J Psychiatry 1984;144:317-319.
-
(1984)
Br. J. Psychiatry
, vol.144
, pp. 317-319
-
-
Barker, W.A.1
Eccleston, D.2
-
22
-
-
0001204978
-
Carbamazepine in affective disorders
-
Emrich HM, Okuma T, Muller AA, editors. Amsterdam: Excerpta Medica
-
Sethi BB, Tiwari SC. Carbamazepine in affective disorders. In: Emrich HM, Okuma T, Muller AA, editors. Anticonvulsants in affective disorders, Amsterdam: Excerpta Medica, 1984. pp. 167-176.
-
(1984)
Anticonvulsants in Affective Disorders
, pp. 167-176
-
-
Sethi, B.B.1
Tiwari, S.C.2
-
23
-
-
0021869192
-
Carbamazepine in manic depressive psychosis
-
Arap MH. Carbamazepine in manic depressive psychosis. East Afr Med J 1985;62:172-174.
-
(1985)
East Afr. Med. J.
, vol.62
, pp. 172-174
-
-
Arap, M.H.1
-
24
-
-
0022401743
-
Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: Case report
-
Nurnberg HG, Finkel JA. Carbamazepine in bipolar-depressed disorder complicated by tricyclic antidepressant switching: case report. J Clin Psychiatry 1985;46:487-488.
-
(1985)
J. Clin. Psychiatry
, vol.46
, pp. 487-488
-
-
Nurnberg, H.G.1
Finkel, J.A.2
-
25
-
-
0022408703
-
Efficacy of carbamazepine as an antidepressant in chronic resistant depressives
-
Prasad AJ. Efficacy of carbamazepine as an antidepressant in chronic resistant depressives. J Indian Med Assoc 1985;83:235-237.
-
(1985)
J. Indian Med. Assoc.
, vol.83
, pp. 235-237
-
-
Prasad, A.J.1
-
26
-
-
0025238817
-
Carbamazepine in the prophylaxis of mood disorders
-
Stuppaeck C, Barnas C, Miller C, Schwitzer J, Fleischhacker WW. Carbamazepine in the prophylaxis of mood disorders. J Clin Psychopharmacol 1990;10:39-42.
-
(1990)
J. Clin. Psychopharmacol.
, vol.10
, pp. 39-42
-
-
Stuppaeck, C.1
Barnas, C.2
Miller, C.3
Schwitzer, J.4
Fleischhacker, W.W.5
-
27
-
-
0025838234
-
Carbamazepine for treatment-resistant melancholia
-
Cullen M, Mitchell P, Brodaty H, et al. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 1991;52:472-476.
-
(1991)
J. Clin. Psychiatry
, vol.52
, pp. 472-476
-
-
Cullen, M.1
Mitchell, P.2
Brodaty, H.3
-
28
-
-
0011638064
-
Clinical experience with carbamazepine in the treatment of acute endogenous depressions
-
Nahunek K, Svestka J, Rysanek R, Obrovska V, Ceskova E, Peska I. Clinical experience with carbamazepine in the treatment of acute endogenous depressions. Activ Nerv Sup 1987;29:181-182.
-
(1987)
Activ. Nerv. Sup.
, vol.29
, pp. 181-182
-
-
Nahunek, K.1
Svestka, J.2
Rysanek, R.3
Obrovska, V.4
Ceskova, E.5
Peska, I.6
-
29
-
-
0030297725
-
Treatment of bipolar depression with carbamazepine: Results of an open study
-
Dilsaver SC, Swann SC, Chen YW, et al. Treatment of bipolar depression with carbamazepine: results of an open study. Biol Psychiatry 1996;40:935-937.
-
(1996)
Biol. Psychiatry
, vol.40
, pp. 935-937
-
-
Dilsaver, S.C.1
Swann, S.C.2
Chen, Y.W.3
-
31
-
-
0001849970
-
Comparative studies of the effect of carbamazepine and trimipramine in depression
-
Emrich HM, Okuma T, Muller AA, editors. Amsterdam: Excerpta Medica
-
Neumann J, Seidel K, Wunderlich H-P. Comparative studies of the effect of carbamazepine and trimipramine in depression. In: Emrich HM, Okuma T, Muller AA, editors. Anticonvulsants in affective disorders, Amsterdam: Excerpta Medica, 1984. pp. 160-166.
-
(1984)
Anticonvulsants in Affective Disorders
, pp. 160-166
-
-
Neumann, J.1
Seidel, K.2
Wunderlich, H.-P.3
-
35
-
-
0025183101
-
Anticonvulsants in affective disorders
-
Small JG. Anticonvulsants in affective disorders. Psychopharmacol Bull 1990;26:25-36.
-
(1990)
Psychopharmacol. Bull.
, vol.26
, pp. 25-36
-
-
Small, J.G.1
-
36
-
-
0032549725
-
Statistical approaches to trial durations in episodic affective illness
-
Post RM, L'Herrou T, Luckenbaugh DA, Frye MA, Leverich GS, Mikalauskas K. Statistical approaches to trial durations in episodic affective illness. Psychiatry Res 1998;78:71-87.
-
(1998)
Psychiatry Res.
, vol.78
, pp. 71-87
-
-
Post, R.M.1
L'Herrou, T.2
Luckenbaugh, D.A.3
Frye, M.A.4
Leverich, G.S.5
Mikalauskas, K.6
-
38
-
-
0011694318
-
Unique design issues in clinical trials of patients with bipolar affective disorder
-
in press
-
Post RM, Luckenbaugh D. Unique design issues in clinical trials of patients with bipolar affective disorder. J Psychiatr Res 2002 in press.
-
(2002)
J. Psychiatr. Res.
-
-
Post, R.M.1
Luckenbaugh, D.2
-
39
-
-
0021690779
-
Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications
-
Roy-Byrne PP, Joffe RT, Uhde TW, Post RM. Carbamazepine and thyroid function in affectively ill patients. Clinical and theoretical implications. Arch Gen Psychiatry 1984;41:1150-1153.
-
(1984)
Arch. Gen. Psychiatry
, vol.41
, pp. 1150-1153
-
-
Roy-Byrne, P.P.1
Joffe, R.T.2
Uhde, T.W.3
Post, R.M.4
-
40
-
-
0032703836
-
Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders
-
Ketter TA, Kimbrell TA, George MS, et al. Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders. Biol Psychiatry 1999;46:1364-1374.
-
(1999)
Biol. Psychiatry
, vol.46
, pp. 1364-1374
-
-
Ketter, T.A.1
Kimbrell, T.A.2
George, M.S.3
-
41
-
-
0027717650
-
Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation
-
Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res 1993;49:257-272.
-
(1993)
Psychiatry Res.
, vol.49
, pp. 257-272
-
-
Pazzaglia, P.J.1
Post, R.M.2
Ketter, T.A.3
George, M.S.4
Marangell, L.B.5
-
42
-
-
0031690746
-
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness
-
Pazzaglia PJ, Post RM, Ketter TA, et al. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol 1998;18:404-413.
-
(1998)
J. Clin. Psychopharmacol.
, vol.18
, pp. 404-413
-
-
Pazzaglia, P.J.1
Post, R.M.2
Ketter, T.A.3
-
43
-
-
0018119821
-
Therapeutic effects of carbamazepine in affective illness: Preliminary report
-
Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: preliminary report. Commun Psychopharmacol 1978;2:159-175.
-
(1978)
Commun. Psychopharmacol.
, vol.2
, pp. 159-175
-
-
Ballenger, J.C.1
Post, R.M.2
-
45
-
-
0019460596
-
A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness
-
Okuma T, Inanaga K, Otsuki S, et al. A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 1981;73:95-96.
-
(1981)
Psychopharmacology
, vol.73
, pp. 95-96
-
-
Okuma, T.1
Inanaga, K.2
Otsuki, S.3
-
46
-
-
0022349748
-
Carbamazepine prophylaxis of affective psychoses (intraindividual comparison with lithium carbonate)
-
Svestka J, Nahunek K, Ceskova E, Korbicka J. Carbamazepine prophylaxis of affective psychoses (intraindividual comparison with lithium carbonate). Activ Nerv Sup 1985;27:261-262.
-
(1985)
Activ. Nerv. Sup.
, vol.27
, pp. 261-262
-
-
Svestka, J.1
Nahunek, K.2
Ceskova, E.3
Korbicka, J.4
-
47
-
-
0003043296
-
Antimanic and prophylactic effects of carbamazepine in affective disorders
-
Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM, editors. New York: Elsevier
-
Kishimoto A, Okuma T. Antimanic and prophylactic effects of carbamazepine in affective disorders. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM, editors. Biological psychiatry 1985, New York: Elsevier, 1986. pp. 883-885.
-
(1986)
Biological Psychiatry 1985
, pp. 883-885
-
-
Kishimoto, A.1
Okuma, T.2
-
48
-
-
0023029861
-
Long-term randomized clinical trial on oxcarbazepine vs. lithium in bipolar and schizoaffective disorders: Preliminary results
-
Cabrera JF, Muhlbauer HD, Schley J, Stoll KD, Muller-Oerlinghausen B. Long-term randomized clinical trial on oxcarbazepine vs. lithium in bipolar and schizoaffective disorders: preliminary results. Pharmacopsychiatry 1986;19:282-283.
-
(1986)
Pharmacopsychiatry
, vol.19
, pp. 282-283
-
-
Cabrera, J.F.1
Muhlbauer, H.D.2
Schley, J.3
Stoll, K.D.4
Muller-Oerlinghausen, B.5
-
49
-
-
0022982141
-
The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients
-
Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986;47:490-494.
-
(1986)
J. Clin. Psychiatry
, vol.47
, pp. 490-494
-
-
Placidi, G.F.1
Lenzi, A.2
Lazzerini, F.3
Cassano, G.B.4
Akiskal, H.S.5
-
50
-
-
0023122139
-
The effect of carbamazepine and lithium on remission from affective illness
-
Watkins SE, Callender K, Thomas DR, Tidmarsh SF, Shaw DM. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 1987;150:180-182.
-
(1987)
Br. J. Psychiatry
, vol.150
, pp. 180-182
-
-
Watkins, S.E.1
Callender, K.2
Thomas, D.R.3
Tidmarsh, S.F.4
Shaw, D.M.5
-
51
-
-
0023733184
-
Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness
-
Elphick M, Lyons F, Cowen PJ. Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness. J Psychopharmacol 1988;2:1-4.
-
(1988)
J. Psychopharmacol.
, vol.2
, pp. 1-4
-
-
Elphick, M.1
Lyons, F.2
Cowen, P.J.3
-
52
-
-
0023790128
-
Carbamazepine vs. lithium in the treatment and prophylaxis of mania
-
Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988;153:198-204.
-
(1988)
Br. J. Psychiatry
, vol.153
, pp. 198-204
-
-
Lusznat, R.M.1
Murphy, D.P.2
Nunn, C.M.3
-
53
-
-
0025215111
-
Carbamazepine vs. lithium. Application in the prophylaxis of recurrent affective and schizoaffective psychoses
-
Bellaire W, Demisch K, Stoll K-D. Carbamazepine vs. lithium. Application in the prophylaxis of recurrent affective and schizoaffective psychoses. Munch Med Wschr 1990;132:S82-S86.
-
(1990)
Munch. Med. Wschr.
, vol.132
-
-
Bellaire, W.1
Demisch, K.2
Stoll, K.-D.3
-
54
-
-
0025732916
-
Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder
-
Di Costanzo E, Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatr Scand 1991;83:456-459.
-
(1991)
Acta Psychiatr. Scand.
, vol.83
, pp. 456-459
-
-
Di Costanzo, E.1
Schifano, F.2
-
55
-
-
0025922939
-
[Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses]
-
Mosolov SN. [Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses]. Zh Nevropatol Psikhiatr 1991;91:78-83.
-
(1991)
Zh Nevropatol Psikhiatr
, vol.91
, pp. 78-83
-
-
Mosolov, S.N.1
-
56
-
-
0026503621
-
Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder
-
Coxhead N, Silverstone T, Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 1992;85:114-118.
-
(1992)
Acta Psychiatr. Scand.
, vol.85
, pp. 114-118
-
-
Coxhead, N.1
Silverstone, T.2
Cookson, J.3
-
57
-
-
0030666691
-
Comparative prophylactic efficacy of lithium, carbamazepine, carbamazepine, and the combination in bipolar disorder
-
Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997;58:470-478.
-
(1997)
J. Clin. Psychiatry
, vol.58
, pp. 470-478
-
-
Denicoff, K.D.1
Smith-Jackson, E.E.2
Disney, E.R.3
Ali, S.O.4
Leverich, G.S.5
Post, R.M.6
-
58
-
-
0000624443
-
Carbamazepine versus lithium in the prophylaxis of bipolar affective disorders: A randomised, doubleblind 1-year study in 168 patients
-
Wolf C, Berky M, Kovacs G. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorders: a randomised, doubleblind 1-year study in 168 patients. Eur Neuropsychopharmacol 1997;7(Suppl 2):S176.
-
(1997)
Eur. Neuropsychopharmacol.
, vol.7
, Issue.SUPPL. 2
-
-
Wolf, C.1
Berky, M.2
Kovacs, G.3
-
59
-
-
0033303189
-
The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder
-
Greil W, Kleindienst N. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 1999;14:277-281.
-
(1999)
Int. Clin. Psychopharmacol.
, vol.14
, pp. 277-281
-
-
Greil, W.1
Kleindienst, N.2
-
60
-
-
0033303289
-
Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified
-
Greil W, Kleindienst N. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol 1999;14:283-285.
-
(1999)
Int. Clin. Psychopharmacol.
, vol.14
, pp. 283-285
-
-
Greil, W.1
Kleindienst, N.2
-
61
-
-
0033824208
-
Lithium and carbamazepine in bipolar disorder
-
Moleman P, Hartong EGTM, Hoogduin CAL, Broekman TG, Nolen WA. . Lithium and carbamazepine in bipolar disorder. Acta Neuropsychiatr 2000;12:120-121.
-
(2000)
Acta Neuropsychiatr.
, vol.12
, pp. 120-121
-
-
Moleman, P.1
Hartong, E.G.T.M.2
Hoogduin, C.A.L.3
Broekman, T.G.4
Nolen, W.A.5
-
62
-
-
0033652406
-
Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: Results of the MAP study
-
Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000;42(Suppl 1):2-10.
-
(2000)
Neuropsychobiology
, vol.42
, Issue.SUPPL. 1
, pp. 2-10
-
-
Kleindienst, N.1
Greil, W.2
-
63
-
-
4243990422
-
Anticonvulsants in bipolar illness with alcohol comorbidity
-
American Psychiatric Association Annual Meeting, Chicago, IL, May 13-18
-
Frye MA, Denicoff KD, Smith-Jackson E, Vanderham E, Leverich GS, Post RM. Anticonvulsants in bipolar illness with alcohol comorbidity. American Psychiatric Association Annual Meeting, Chicago, IL, May 13-18, 2000.
-
(2000)
-
-
Frye, M.A.1
Denicoff, K.D.2
Smith-Jackson, E.3
Vanderham, E.4
Leverich, G.S.5
Post, R.M.6
-
64
-
-
0026635462
-
Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: A double-blind study
-
Stuppaeck CH, Pycha R, Miller C, Whitworth AB, Oberbauer H, Fleischhacker WW. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol 1992;27:153-158.
-
(1992)
Alcohol Alcohol
, vol.27
, pp. 153-158
-
-
Stuppaeck, C.H.1
Pycha, R.2
Miller, C.3
Whitworth, A.B.4
Oberbauer, H.5
Fleischhacker, W.W.6
-
65
-
-
0020064463
-
Treatment of acute alcohol withdrawal syndrome with carbamazepine: A doubleblind comparison with tiapride
-
Agricola R, Mazzarino M, Urani R, Gallo V, Grossi E. Treatment of acute alcohol withdrawal syndrome with carbamazepine: a doubleblind comparison with tiapride. J Int Med Res 1982;10:160-165.
-
(1982)
J. Int. Med. Res.
, vol.10
, pp. 160-165
-
-
Agricola, R.1
Mazzarino, M.2
Urani, R.3
Gallo, V.4
Grossi, E.5
-
66
-
-
0021262671
-
Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses
-
Ballenger JC, Post RM. Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull 1984;20:572-584.
-
(1984)
Psychopharmacol. Bull.
, vol.20
, pp. 572-584
-
-
Ballenger, J.C.1
Post, R.M.2
-
67
-
-
0028281080
-
Efficacy of divalproex vs. lithium and placebo in the treatment of mania
-
The Depakote Mania Study Group
-
Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. J Am Med Assoc 1994;271:918-924.
-
(1994)
J. Am. Med. Assoc.
, vol.271
, pp. 918-924
-
-
Bowden, C.L.1
Brugger, A.M.2
Swann, A.C.3
-
68
-
-
0026530896
-
A double-blind comparison of valproate and lithium in the treatment of acute mania
-
Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-111.
-
(1992)
Am. J. Psychiatry
, vol.149
, pp. 108-111
-
-
Freeman, T.W.1
Clothier, J.L.2
Pazzaglia, P.3
Lesem, M.D.4
Swann, A.C.5
-
69
-
-
0002317657
-
Clinical efficacy of valproate
-
Joffe RT, Calabrese JR, editors. New York: Marcel Dekker
-
Calabrese JR, Woyshville MJ, Rapport RT. Clinical efficacy of valproate. In: Joffe RT, Calabrese JR, editors. Anticonvulsants in mood disorders, New York: Marcel Dekker, 1994. pp. 131-146.
-
(1994)
Anticonvulsants in Mood Disorders
, pp. 131-146
-
-
Calabrese, J.R.1
Woyshville, M.J.2
Rapport, R.T.3
-
71
-
-
0037952730
-
Divalproex versus placebo for the treatment of bipolar depression
-
Sachs G, Altshuler L, Ketter T, Suppes T, Rasgon N, Frye M, et al. Divalproex versus placebo for the treatment of bipolar depression. ACNP Abstr 2001:232.
-
(2001)
ACNP Abstr.
, pp. 232
-
-
Sachs, G.1
Altshuler, L.2
Ketter, T.3
Suppes, T.4
Rasgon, N.5
Frye, M.6
-
72
-
-
0002299950
-
Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide)
-
Emrich HM, Okuma T, Muller AA, editors. Amsterdam: Excerpta Medica
-
Lambert PA. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okuma T, Muller AA, editors. Anticonvulsants in affective disorders, Amsterdam: Excerpta Medica, 1984. pp. 33-44.
-
(1984)
Anticonvulsants in Affective Disorders
, pp. 33-44
-
-
Lambert, P.A.1
-
73
-
-
0023605089
-
[Use of valpromide in psychiatric therapeutics]
-
Lambert PA, Venaud G. [Use of valpromide in psychiatric therapeutics]. Encephale 1987;13:367-373.
-
(1987)
Encephale
, vol.13
, pp. 367-373
-
-
Lambert, P.A.1
Venaud, G.2
-
76
-
-
0001966149
-
Comparative study of valpromide vs. lithium as prophylactic treatments in affective disorders
-
Lambert PA, Venaud G. Comparative study of valpromide vs. lithium as prophylactic treatments in affective disorders. Nerv J Psychiatr 1995:1-9.
-
(1995)
Nerv. J. Psychiatr.
, pp. 1-9
-
-
Lambert, P.A.1
Venaud, G.2
-
77
-
-
0034013393
-
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder
-
Divalproex Maintenance Study Group
-
Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-489.
-
(2000)
Arch. Gen. Psychiatry
, vol.57
, pp. 481-489
-
-
Bowden, C.L.1
Calabrese, J.R.2
McElroy, S.L.3
-
79
-
-
0027322803
-
Valproate treatment of panic disorder and lactate-induced panic attacks
-
Keck PEJ, Taylor VE, Tugrul KC, McElroy SL, Bennett JA. Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 1993;33:542-546.
-
(1993)
Biol. Psychiatry
, vol.33
, pp. 542-546
-
-
Keck, P.E.J.1
Taylor, V.E.2
Tugrul, K.C.3
McElroy, S.L.4
Bennett, J.A.5
-
80
-
-
0031012799
-
Depression during mania. Treatment response to lithium or divalproex
-
Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997;54:37-42.
-
(1997)
Arch. Gen. Psychiatry
, vol.54
, pp. 37-42
-
-
Swann, A.C.1
Bowden, C.L.2
Morris, D.3
-
84
-
-
0028323487
-
Panic disorder: Treatment with valproate
-
Woodman CL, Noyes RJ. Panic disorder: treatment with valproate. J Clin Psychiatry 1994;55:134-136.
-
(1994)
J. Clin. Psychiatry
, vol.55
, pp. 134-136
-
-
Woodman, C.L.1
Noyes, R.J.2
-
85
-
-
0026742320
-
GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate
-
Motohashi N. GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:571-579.
-
(1992)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.16
, pp. 571-579
-
-
Motohashi, N.1
-
86
-
-
0019400439
-
On the possible role of GABA in mania. Therapeutic efficacy of sodium valproate
-
Costa E, editor. New York: Raven
-
Emrich HM, Von Zerssen D, Kissling W, Moller H-J. On the possible role of GABA in mania. Therapeutic efficacy of sodium valproate. In: Costa E, editor. GABA and benzodiazepine receptors, New York: Raven, 1981. pp. 287-296.
-
(1981)
GABA and Benzodiazepine Receptors
, pp. 287-296
-
-
Emrich, H.M.1
Von Zerssen, D.2
Kissling, W.3
Moller, H.-J.4
-
87
-
-
0002710089
-
Lithium, carbamazepine, and valproate in affective illness: Biochemical and neurobiological mechanisms
-
Manji H, Bowden CL, Belmaker RH, editors. Washington, DC: American Psychiatric Press
-
Post RM, Weiss SRB, Clark M, Chuang DM, Hough C, Li H. Lithium, carbamazepine, and valproate in affective illness: biochemical and neurobiological mechanisms. In: Manji H, Bowden CL, Belmaker RH, editors. Bipolar medications: mechanisms of action, Washington, DC: American Psychiatric Press, 2000. pp. 219-248.
-
(2000)
Bipolar Medications: Mechanisms of Action
, pp. 219-248
-
-
Post, R.M.1
Weiss, S.R.B.2
Clark, M.3
Chuang, D.M.4
Hough, C.5
Li, H.6
-
88
-
-
0033697737
-
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
-
Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-614.
-
(2000)
J. Clin. Psychopharmacol.
, vol.20
, pp. 607-614
-
-
Frye, M.A.1
Ketter, T.A.2
Kimbrell, T.A.3
-
89
-
-
0034278763
-
Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy
-
Gabapentin Bipolar Disorder Study Group
-
Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000;2:249-255.
-
(2000)
Bipolar. Disord.
, vol.2
, pp. 249-255
-
-
Pande, A.C.1
Crockatt, J.G.2
Janney, C.A.3
Werth, J.L.4
Tsaroucha, G.5
-
90
-
-
0032733148
-
Tiagabine appears not to be efficacious in the treatment of acute mania
-
Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J. Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry 1999;60:759-762.
-
(1999)
J. Clin. Psychiatry
, vol.60
, pp. 759-762
-
-
Grunze, H.1
Erfurth, A.2
Marcuse, A.3
Amann, B.4
Normann, C.5
Walden, J.6
-
91
-
-
0033004838
-
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
-
Lamictal 602 Study Group
-
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60:79-88.
-
(1999)
J. Clin. Psychiatry
, vol.60
, pp. 79-88
-
-
Calabrese, J.R.1
Bowden, C.L.2
Sachs, G.S.3
Ascher, J.A.4
Monaghan, E.5
Rudd, G.D.6
-
92
-
-
0031754858
-
Clinical studies on the use of lamotrigine in bipolar disorder
-
Calabrese JR, Rapport DJ, Shelton MD, Kujawa M, Kimmel SE. Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology 1998;38:185-191.
-
(1998)
Neuropsychobiology
, vol.38
, pp. 185-191
-
-
Calabrese, J.R.1
Rapport, D.J.2
Shelton, M.D.3
Kujawa, M.4
Kimmel, S.E.5
-
93
-
-
0342301745
-
Lamotrigine-associated rash: Risk/benefit considerations in adults and children
-
Guberman AH, Besag FM, Brodie MJ, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999;40:985-991.
-
(1999)
Epilepsia
, vol.40
, pp. 985-991
-
-
Guberman, A.H.1
Besag, F.M.2
Brodie, M.J.3
-
94
-
-
0031555277
-
Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP
-
Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997;73:159-171.
-
(1997)
Psychiatry Res.
, vol.73
, pp. 159-171
-
-
Spearing, M.K.1
Post, R.M.2
Leverich, G.S.3
Brandt, D.4
Nolen, W.5
-
95
-
-
0036468685
-
Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders
-
Obrocea GV, Dunn RM, Frye MA, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 2002;51:253-260.
-
(2002)
Biol. Psychiatry
, vol.51
, pp. 253-260
-
-
Obrocea, G.V.1
Dunn, R.M.2
Frye, M.A.3
-
96
-
-
0034005897
-
Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: Cross-tolerance to carbamazepine but not valproate or diazepam
-
Krupp E, Heynen T, Li XL, Post RM, Weiss SR. Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam. Exp Neurol 2000;162:278-289.
-
(2000)
Exp. Neurol.
, vol.162
, pp. 278-289
-
-
Krupp, E.1
Heynen, T.2
Li, X.L.3
Post, R.M.4
Weiss, S.R.5
-
97
-
-
0030454477
-
Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones
-
Wang SJ, Huang CC, Hsu KS, Tsai JJ, Gean PW. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. Neuroreport 1996;7:3037-3040.
-
(1996)
Neuroreport
, vol.7
, pp. 3037-3040
-
-
Wang, S.J.1
Huang, C.C.2
Hsu, K.S.3
Tsai, J.J.4
Gean, P.W.5
-
99
-
-
0033051765
-
Lamictal (lamotrigine) monotherapy for typical absence seizures in children
-
Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-979.
-
(1999)
Epilepsia
, vol.40
, pp. 973-979
-
-
Frank, L.M.1
Enlow, T.2
Holmes, G.L.3
-
101
-
-
0036501615
-
Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression
-
Dunn RT, Kimbrell TA, Ketter TA, et al. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry 2002;51:387-399.
-
(2002)
Biol. Psychiatry
, vol.51
, pp. 387-399
-
-
Dunn, R.T.1
Kimbrell, T.A.2
Ketter, T.A.3
-
102
-
-
0022879349
-
Preliminary study of carbamazepine in post-traumatic stress disorder
-
Lipper S, Davidson JRT, Grady TA, et al. Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics 1986;27:849-854.
-
(1986)
Psychosomatics
, vol.27
, pp. 849-854
-
-
Lipper, S.1
Davidson, J.R.T.2
Grady, T.A.3
-
103
-
-
0024444903
-
Sleep disorders and depression with atypical features: Response to valproate
-
Pies R, Adler DA, Ehrenberg BL. Sleep disorders and depression with atypical features: response to valproate. J Clin Psychopharmacol 1989;9:352-357.
-
(1989)
J. Clin. Psychopharmacol.
, vol.9
, pp. 352-357
-
-
Pies, R.1
Adler, D.A.2
Ehrenberg, B.L.3
-
104
-
-
0026558528
-
Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes
-
Keck PEJ, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992;12:36S-41S.
-
(1992)
J. Clin. Psychopharmacol.
, vol.12
-
-
Keck, P.E.J.1
McElroy, S.L.2
Friedman, L.M.3
-
106
-
-
0029837862
-
Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder
-
Walden J, Hesslinger B, Van Calker D, Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry 1996;29:193-195.
-
(1996)
Pharmacopsychiatry
, vol.29
, pp. 193-195
-
-
Walden, J.1
Hesslinger, B.2
Van Calker, D.3
Berger, M.4
-
107
-
-
0011633643
-
Lamotrigine in bipolar disorder: Preliminary data
-
Syllabus and proceedings summary of the 150th American Psychiatric Association Meeting, May 17-22
-
Calabrese JR, Bowden CL, McElroy SL, Cookson J, Anderson J, Rhodes LJ, et al. Lamotrigine in bipolar disorder: preliminary data. Syllabus and proceedings summary of the 150th American Psychiatric Association Meeting, May 17-22, 1997.
-
(1997)
-
-
Calabrese, J.R.1
Bowden, C.L.2
McElroy, S.L.3
Cookson, J.4
Anderson, J.5
Rhodes, L.J.6
-
109
-
-
0030762529
-
Lamotrigine treatment of refractory bipolar disorder
-
Fogelson DL, Sternbach H. Lamotrigine treatment of refractory bipolar disorder. J Clin Psychiatry 1997;58:271-273.
-
(1997)
J. Clin. Psychiatry
, vol.58
, pp. 271-273
-
-
Fogelson, D.L.1
Sternbach, H.2
-
111
-
-
0030910672
-
The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness
-
Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185-189.
-
(1997)
J. Clin. Psychopharmacol.
, vol.17
, pp. 185-189
-
-
Sporn, J.1
Sachs, G.2
-
112
-
-
0030855447
-
Lamotrigine treatment of rapid cycling bipolar disorder
-
[letter; comment]
-
Kusumakar V, Yatham LN. Lamotrigine treatment of rapid cycling bipolar disorder [letter; comment]. Am J Psychiatry 1997;154:1171-1172.
-
(1997)
Am. J. Psychiatry
, vol.154
, pp. 1171-1172
-
-
Kusumakar, V.1
Yatham, L.N.2
-
113
-
-
0030778964
-
An open study of lamotrigine in refractory bipolar depression
-
Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145-148.
-
(1997)
Psychiatry Res.
, vol.72
, pp. 145-148
-
-
Kusumakar, V.1
Yatham, L.N.2
-
114
-
-
0003042752
-
Lamotrigine/valproate in treatment resistant bipolar disorder in children and adolescents
-
Mandoki M. Lamotrigine/valproate in treatment resistant bipolar disorder in children and adolescents. Biol Psychiatry 1997;41:93S-94S.
-
(1997)
Biol. Psychiatry
, vol.41
-
-
Mandoki, M.1
-
115
-
-
0031952012
-
Lamotrigine in the treatment of resistant bipolar disorder
-
Kotler M, Matar MA. Lamotrigine in the treatment of resistant bipolar disorder. Clin Neuropharmacol 1998;21:65-67.
-
(1998)
Clin. Neuropharmacol.
, vol.21
, pp. 65-67
-
-
Kotler, M.1
Matar, M.A.2
-
117
-
-
0033561206
-
The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder
-
Bowden CL, Calabrese JR, McElroy SL, et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry 1999;45:953-958.
-
(1999)
Biol. Psychiatry
, vol.45
, pp. 953-958
-
-
Bowden, C.L.1
Calabrese, J.R.2
McElroy, S.L.3
-
118
-
-
0032913616
-
Lamotrigine for the treatment of bipolar disorder: A clinical case series
-
Suppes T, Brown ES, McElroy SL, et al. Lamotrigine for the treatment of bipolar disorder: a clinical case series. J Affect Disord 1999;53:95-98.
-
(1999)
J. Affect. Disord.
, vol.53
, pp. 95-98
-
-
Suppes, T.1
Brown, E.S.2
McElroy, S.L.3
-
119
-
-
0034569460
-
An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization
-
Walden J, Schaerer L, Schloesser S, Grunze H. An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization. Bipolar Disord 2000;2:336-339.
-
(2000)
Bipolar. Disord.
, vol.2
, pp. 336-339
-
-
Walden, J.1
Schaerer, L.2
Schloesser, S.3
Grunze, H.4
-
120
-
-
0033815917
-
Use of lamotrigine in a patient with bipolar disorder and psychiatric comorbidity
-
Ballasiotes AA, Skaer TL. Use of lamotrigine in a patient with bipolar disorder and psychiatric comorbidity. Clin Ther 2000;22:1146-1148.
-
(2000)
Clin. Ther.
, vol.22
, pp. 1146-1148
-
-
Ballasiotes, A.A.1
Skaer, T.L.2
-
121
-
-
0034090550
-
Lamotrigine compared with lithium in mania: A double-blind randomized controlled trial
-
Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000;12:5-10.
-
(2000)
Ann. Clin. Psychiatry
, vol.12
, pp. 5-10
-
-
Ichim, L.1
Berk, M.2
Brook, S.3
-
122
-
-
0033696203
-
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder
-
Lamictal 614 Study Group
-
Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841-850.
-
(2000)
J. Clin. Psychiatry
, vol.61
, pp. 841-850
-
-
Calabrese, J.R.1
Suppes, T.2
Bowden, C.L.3
-
123
-
-
0037385145
-
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder
-
in press
-
Bowden CL, Calabrese JR, Sachs GS, Yatham LN, Ashgar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2002 in press.
-
(2002)
Arch. Gen. Psychiatry
-
-
Bowden, C.L.1
Calabrese, J.R.2
Sachs, G.S.3
Yatham, L.N.4
Ashgar, S.A.5
Hompland, M.6
-
124
-
-
0002486910
-
Summary and meta-analysis of two large placebo-controlled 18-month maintenance trials of lamotrigine and lithium treatment in bipolar I disorder
-
Calabrese JR, Soegaard J, Hompland M, Mehtonen OP, Ruetsch G, Paska W. Summary and meta-analysis of two large placebo-controlled 18-month maintenance trials of lamotrigine and lithium treatment in bipolar I disorder. Int J Neuropsychopharmacol 2002;5:S58.
-
(2002)
Int. J. Neuropsychopharmacol.
, vol.5
-
-
Calabrese, J.R.1
Soegaard, J.2
Hompland, M.3
Mehtonen, O.P.4
Ruetsch, G.5
Paska, W.6
-
125
-
-
0002536908
-
Clinical presentation of bipolar disorders responsive to lithium or lamotrigine
-
Alda M, Passmore MJ, Garnham J, et al. Clinical presentation of bipolar disorders responsive to lithium or lamotrigine. Int J Neuropsychopharmacol 2002;5:S58.
-
(2002)
Int. J. Neuropsychopharmacol.
, vol.5
-
-
Alda, M.1
Passmore, M.J.2
Garnham, J.3
-
126
-
-
0030978468
-
Gabapentin for treatment of bipolar and schizoaffective disorders
-
Bennett J, Goldman WT, Suppes T. Gabapentin for treatment of bipolar and schizoaffective disorders. J Clin Psychopharmacol 1997;17:141-142.
-
(1997)
J. Clin. Psychopharmacol.
, vol.17
, pp. 141-142
-
-
Bennett, J.1
Goldman, W.T.2
Suppes, T.3
-
130
-
-
0031029401
-
Gabapentin in the treatment of bipolar disorder
-
[letter]
-
Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder [letter]. Am J Psychiatry 1997;154:291-292.
-
(1997)
Am. J. Psychiatry
, vol.154
, pp. 291-292
-
-
Schaffer, C.B.1
Schaffer, L.C.2
-
132
-
-
0030813131
-
Acute treatment of bipolar depression with gabapentin
-
Young LT, Robb JC, Patelis-Siotis I, MacDonald C, Joffe RT. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry 1997;42:851-853.
-
(1997)
Biol. Psychiatry
, vol.42
, pp. 851-853
-
-
Young, L.T.1
Robb, J.C.2
Patelis-Siotis, I.3
MacDonald, C.4
Joffe, R.T.5
-
133
-
-
0031980513
-
Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania
-
Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998;49:229-233.
-
(1998)
J. Affect. Disord.
, vol.49
, pp. 229-233
-
-
Knoll, J.1
Stegman, K.2
Suppes, T.3
-
134
-
-
0032168304
-
An open label study of gabapentin in the treatment of acute mania
-
Erfurth A, Kammerer C, Grunze H, Normann C, Walden J. An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res 1998;32:261-264.
-
(1998)
J. Psychiatr. Res.
, vol.32
, pp. 261-264
-
-
Erfurth, A.1
Kammerer, C.2
Grunze, H.3
Normann, C.4
Walden, J.5
-
136
-
-
0033188208
-
Gabapentin in the acute treatment of refractory bipolar disorder
-
Altshuler LL, Keck Jr PE, McElroy SL, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1999;1:61-65.
-
(1999)
Bipolar. Disord.
, vol.1
, pp. 61-65
-
-
Altshuler, L.L.1
Keck P.E., Jr.2
McElroy, S.L.3
-
137
-
-
0032910702
-
Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: Results of an open-label study
-
Cabras PL, Hardoy MJ, Hardoy MC, Carta MG. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: results of an open-label study. J Clin Psychiatry 1999;60:245-248.
-
(1999)
J. Clin. Psychiatry
, vol.60
, pp. 245-248
-
-
Cabras, P.L.1
Hardoy, M.J.2
Hardoy, M.C.3
Carta, M.G.4
-
138
-
-
0033773559
-
Adjunctive gabapentin treatment of bipolar disorder
-
Vieta E, Martinez-Aran A, Nieto E, et al. Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry 2000;15:433-437.
-
(2000)
Eur. Psychiatry
, vol.15
, pp. 433-437
-
-
Vieta, E.1
Martinez-Aran, A.2
Nieto, E.3
-
139
-
-
0035026069
-
Gabapentin treatment of the non-refractory bipolar spectrum: An open case series
-
Ghaemi SN, Goodwin FK. Gabapentin treatment of the non-refractory bipolar spectrum: an open case series. J Affect Disord 2001;65:167-171.
-
(2001)
J. Affect. Disord.
, vol.65
, pp. 167-171
-
-
Ghaemi, S.N.1
Goodwin, F.K.2
-
140
-
-
0035053060
-
Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders
-
Carta MG, Hardoy MC, Dessi I, Hardoy MJ, Carpiniello B. Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders. J Intellect Disabil Res 2001;45:139-145.
-
(2001)
J. Intellect. Disabil. Res.
, vol.45
, pp. 139-145
-
-
Carta, M.G.1
Hardoy, M.C.2
Dessi, I.3
Hardoy, M.J.4
Carpiniello, B.5
-
141
-
-
0035089210
-
Gabapentin and the prophylaxis of bipolar disorders in patients intolerant to lithium
-
Mauri MC, Laini V, Scalvini ME, et al. Gabapentin and the prophylaxis of bipolar disorders in patients intolerant to lithium. Clin Drug Invest 2001;21:169-174.
-
(2001)
Clin. Drug Invest.
, vol.21
, pp. 169-174
-
-
Mauri, M.C.1
Laini, V.2
Scalvini, M.E.3
-
142
-
-
0035206268
-
Gabapentin use in geriatric patients with depression and bipolar illness
-
Robillard M, Conn D. Gabapentin use in geriatric patients with depression and bipolar illness. Can J Psychiatry 2001;46:764.
-
(2001)
Can. J. Psychiatry
, vol.46
, pp. 764
-
-
Robillard, M.1
Conn, D.2
-
144
-
-
0033942108
-
Placebo-controlled study of gabapentin treatment of panic disorder
-
Pande AC, Pollack MH, Crockatt J, et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 2000;20:467-471.
-
(2000)
J. Clin. Psychopharmacol.
, vol.20
, pp. 467-471
-
-
Pande, A.C.1
Pollack, M.H.2
Crockatt, J.3
-
145
-
-
0035722908
-
Demographics and illness characteristics of the first 261 patients
-
The Stanley Foundation Bipolar Treatment Outcome Network. II
-
Suppes T, Leverich GS, Keck PE, et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord 2001;67:45-59.
-
(2001)
J. Affect. Disord.
, vol.67
, pp. 45-59
-
-
Suppes, T.1
Leverich, G.S.2
Keck, P.E.3
-
146
-
-
0035096665
-
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder
-
McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158: 420-426.
-
(2001)
Am. J. Psychiatry
, vol.158
, pp. 420-426
-
-
McElroy, S.L.1
Altshuler, L.L.2
Suppes, T.3
-
147
-
-
0036176898
-
The comorbidity of bipolar and anxiety disorders: Prevalence, psychobiology, and treatment issues
-
Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002;68:1-23.
-
(2002)
J. Affect. Disord.
, vol.68
, pp. 1-23
-
-
Freeman, M.P.1
Freeman, S.A.2
McElroy, S.L.3
-
148
-
-
0032848061
-
Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs
-
White HS. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 1999;40(Suppl 5):S2-S10.
-
(1999)
Epilepsia
, vol.40
, Issue.SUPPL. 5
-
-
White, H.S.1
-
149
-
-
0031883542
-
A summary of mechanistic hypotheses of gabapentin pharmacology
-
Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998;29:233-249.
-
(1998)
Epilepsy Res.
, vol.29
, pp. 233-249
-
-
Taylor, C.P.1
Gee, N.S.2
Su, T.Z.3
-
150
-
-
0036137829
-
Treatment of alcohol withdrawal with gabapentin
-
Bozikas V, Petrikis P, Gamvrula K, Savvidou I, Karavatos A. Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:197-199.
-
(2002)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.26
, pp. 197-199
-
-
Bozikas, V.1
Petrikis, P.2
Gamvrula, K.3
Savvidou, I.4
Karavatos, A.5
-
152
-
-
0031716650
-
Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder
-
Cora-Locatelli G, Greenberg BD, Martin J, Murphy DL. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder. J Clin Psychiatry 1998;59:480-481.
-
(1998)
J. Clin. Psychiatry
, vol.59
, pp. 480-481
-
-
Cora-Locatelli, G.1
Greenberg, B.D.2
Martin, J.3
Murphy, D.L.4
-
153
-
-
0030898703
-
Treatment of restless legs syndrome with gabapentin
-
Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 1997;20:148-151.
-
(1997)
Clin. Neuropharmacol.
, vol.20
, pp. 148-151
-
-
Adler, C.H.1
-
154
-
-
0031859210
-
Gabapentin for treatment of pain and tremor: A large case series
-
Merren MD. Gabapentin for treatment of pain and tremor: a large case series. South Med J 1998;91:739-744.
-
(1998)
South Med. J.
, vol.91
, pp. 739-744
-
-
Merren, M.D.1
-
155
-
-
0031126348
-
A pharmacological and clinical review on topiramate, a new antiepileptic drug
-
Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 1997;35:241-256.
-
(1997)
Pharmacol. Res.
, vol.35
, pp. 241-256
-
-
Perucca, E.1
-
157
-
-
0035040961
-
Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: A case-series
-
Roy Chengappa KN, Levine J, Rathore D, Parepally H, Atzert R. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. Eur Psychiatry 2001;16:186-190.
-
(2001)
Eur. Psychiatry
, vol.16
, pp. 186-190
-
-
Roy Chengappa, K.N.1
Levine, J.2
Rathore, D.3
Parepally, H.4
Atzert, R.5
-
158
-
-
0033188340
-
Topiramate as add-on treatment for patients with bipolar mania
-
Chengappa KN, Rathore D, Levine J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999;1:42-53.
-
(1999)
Bipolar. Disord.
, vol.1
, pp. 42-53
-
-
Chengappa, K.N.1
Rathore, D.2
Levine, J.3
-
159
-
-
0034128353
-
Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults
-
Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(Suppl 1):S66-S71.
-
(2000)
Epilepsia
, vol.41
, Issue.SUPPL. 1
-
-
Reife, R.1
Pledger, G.2
Wu, S.C.3
-
160
-
-
0032171131
-
Use of topiramate, a new anti-epileptic as a mood stabilizer
-
Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 1998;50:245-251.
-
(1998)
J. Affect. Disord.
, vol.50
, pp. 245-251
-
-
Marcotte, D.1
-
161
-
-
0002452879
-
Topiramate augmentation in women with refractory rapid cycling bipolar disorder and significant weight gain from previous treatment
-
Kusumakar V, Yatham LN, O'Donovan C, Kutcher SP. Topiramate augmentation in women with refractory rapid cycling bipolar disorder and significant weight gain from previous treatment. Bipolar Disord 1999;1(Suppl 1):38-39.
-
(1999)
Bipolar. Disord.
, vol.1
, Issue.SUPPL. 1
, pp. 38-39
-
-
Kusumakar, V.1
Yatham, L.N.2
O'Donovan, C.3
Kutcher, S.P.4
-
162
-
-
0034128399
-
Open-label adjunctive topiramate in the treatment of bipolar disorders
-
McElroy SL, Suppes T, Keck PE, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000;47:1025-1033.
-
(2000)
Biol. Psychiatry
, vol.47
, pp. 1025-1033
-
-
McElroy, S.L.1
Suppes, T.2
Keck, P.E.3
-
163
-
-
0033188340
-
Topiramate as add-on treatment for patients with bipolar mania
-
Chengappa RKN, Rathore D, Levine J, et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999;1:42 53.
-
(1999)
Bipolar. Disord.
, vol.1
, pp. 42-53
-
-
Chengappa, R.K.N.1
Rathore, D.2
Levine, J.3
-
164
-
-
0036268105
-
Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study
-
McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 2002;4:207-213.
-
(2002)
Bipolar. Disord.
, vol.4
, pp. 207-213
-
-
McIntyre, R.S.1
Mancini, D.A.2
McCann, S.3
Srinivasan, J.4
Sagman, D.5
Kennedy, S.H.6
-
165
-
-
0034894516
-
Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design
-
Grunze HC, Normann C, Langosch J, et al. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design. J Clin Psychiatry 2001;62:464-468.
-
(2001)
J. Clin. Psychiatry
, vol.62
, pp. 464-468
-
-
Grunze, H.C.1
Normann, C.2
Langosch, J.3
-
166
-
-
0034899398
-
Topiramate in posttraumatic stress disorder: Preliminary clinical observations
-
Berlant JL. Topiramate in posttraumatic stress disorder: preliminary clinical observations. J Clin Psychiatry 2001;62(Suppl 17):60-63.
-
(2001)
J. Clin. Psychiatry
, vol.62
, Issue.SUPPL. 17
, pp. 60-63
-
-
Berlant, J.L.1
-
167
-
-
0027420928
-
Postsynaptic factors in the expression of long-term potentiation (LTP): Increased glutamate receptor binding following LTP induction in vivo
-
Maren S, Tocco G, Standley S, Baudry M, Thompson RF. Postsynaptic factors in the expression of long-term potentiation (LTP): increased glutamate receptor binding following LTP induction in vivo. Proc Natl Acad Sci USA 1993;90:9654-9658.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 9654-9658
-
-
Maren, S.1
Tocco, G.2
Standley, S.3
Baudry, M.4
Thompson, R.F.5
-
168
-
-
0027941257
-
Synaptic plasticity in the hippocampus: LTP and LTD
-
Malenka RC. Synaptic plasticity in the hippocampus: LTP and LTD. Cell 1994;78:535-538.
-
(1994)
Cell
, vol.78
, pp. 535-538
-
-
Malenka, R.C.1
-
169
-
-
33947109040
-
Psychosocial stressors as predisposing factors to affective illness and PTSD: Potential neurobiological mechanisms and theoretical implications
-
Cicchetti D, Walker E, editors. New York: Cambridge University Press in press
-
Post RM, Leverich GS, Weiss SR, Zhang LX, Li H, Smith M. Psychosocial stressors as predisposing factors to affective illness and PTSD: potential neurobiological mechanisms and theoretical implications. In: Cicchetti D, Walker E, editors. Neurodevelopmental mechanisms in psychopathology, New York: Cambridge University Press, 2001, in press.
-
(2001)
Neurodevelopmental Mechanisms in Psychopathology
-
-
Post, R.M.1
Leverich, G.S.2
Weiss, S.R.3
Zhang, L.X.4
Li, H.5
Smith, M.6
-
170
-
-
0033816145
-
A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures
-
Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178.
-
(2000)
Epilepsia
, vol.41
, pp. 1167-1178
-
-
Aldenkamp, A.P.1
Baker, G.2
Mulder, O.G.3
-
171
-
-
0021713537
-
CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls
-
Gerner RH, Fairbanks L, Anderson GM, et al. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am J Psychiatry 1984;141:1533-1540.
-
(1984)
Am. J. Psychiatry
, vol.141
, pp. 1533-1540
-
-
Gerner, R.H.1
Fairbanks, L.2
Anderson, G.M.3
-
172
-
-
0002024046
-
GABA and depression
-
Mann JJ, Kupfer DJ, editors. New York: Plenum
-
Petty F, Kramer GL, Hendrickse W. GABA and depression. In: Mann JJ, Kupfer DJ, editors. Biology of depressive disorders, part A: a systems perspective, New York: Plenum, 1993. pp. 79-108.
-
(1993)
Biology of Depressive Disorders, Part A: A Systems Perspective
, pp. 79-108
-
-
Petty, F.1
Kramer, G.L.2
Hendrickse, W.3
-
173
-
-
0032697988
-
Tiagabine and the treatment of refractory bipolar disorder
-
Schaffer LC, Schaffer CB. Tiagabine and the treatment of refractory bipolar disorder. Am J Psychiatry 1999;156:2014-2015.
-
(1999)
Am. J. Psychiatry
, vol.156
, pp. 2014-2015
-
-
Schaffer, L.C.1
Schaffer, C.B.2
-
174
-
-
0032464043
-
Adjunctive tiagabine treatment of psychiatric disorders: Three cases
-
Kaufman KR. Adjunctive tiagabine treatment of psychiatric disorders: three cases. Ann Clin Psychiatry 1998;10:181-184.
-
(1998)
Ann. Clin. Psychiatry
, vol.10
, pp. 181-184
-
-
Kaufman, K.R.1
-
175
-
-
0011684330
-
Tiagabine in bipolar disorder: Adverse events in an open case series
-
Suppes T, Chisholm K, Dhvule D, Frye M, Altshuler L, McElroy S, et al. Tiagabine in bipolar disorder: adverse events in an open case series. 2002.
-
(2002)
-
-
Suppes, T.1
Chisholm, K.2
Dhvule, D.3
Frye, M.4
Altshuler, L.5
McElroy, S.6
-
176
-
-
0031747791
-
Nonconvulsive status epilepticus in two patients receiving tiagabine treatment
-
Eckardt KM, Steinhoff BJ. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 1998;39:671-674.
-
(1998)
Epilepsia
, vol.39
, pp. 671-674
-
-
Eckardt, K.M.1
Steinhoff, B.J.2
-
177
-
-
0033180239
-
Tiagabine-induced absence status in idiopathic generalized epilepsy
-
Knake S, Hamer HM, Schomburg U, Oertel WH, Rosenow F. Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure 1999;8:314-317.
-
(1999)
Seizure
, vol.8
, pp. 314-317
-
-
Knake, S.1
Hamer, H.M.2
Schomburg, U.3
Oertel, W.H.4
Rosenow, F.5
-
178
-
-
0030035708
-
Mechanisms of T-type calcium channel blockade by zonisamide
-
Kito M, Maehara M, Watanabe K. Mechanisms of T-type calcium channel blockade by zonisamide. Seizure 1996;5:115-119.
-
(1996)
Seizure
, vol.5
, pp. 115-119
-
-
Kito, M.1
Maehara, M.2
Watanabe, K.3
-
179
-
-
0025405649
-
Interaction of zonisamide with benzodiazepine and GABA receptors in rat brain
-
Mimaki T, Suzuki Y, Tagawa T, Karasawa T, Yabuuchi H. Interaction of zonisamide with benzodiazepine and GABA receptors in rat brain. Med J Osaka Univ 1990;39:13-17.
-
(1990)
Med. J. Osaka Univ.
, vol.39
, pp. 13-17
-
-
Mimaki, T.1
Suzuki, Y.2
Tagawa, T.3
Karasawa, T.4
Yabuuchi, H.5
-
180
-
-
0028860733
-
Effects of zonisamide on dopaminergic system
-
Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995;22:193-205.
-
(1995)
Epilepsy Res.
, vol.22
, pp. 193-205
-
-
Okada, M.1
Kaneko, S.2
Hirano, T.3
-
183
-
-
0027938365
-
The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania
-
Kanba S, Yagi G, Kamijima K, et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:707-715.
-
(1994)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.18
, pp. 707-715
-
-
Kanba, S.1
Yagi, G.2
Kamijima, K.3
-
184
-
-
0032563178
-
Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
-
Klitgaard H, Matagne A, Gobert J, Wulfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 1998;353:191-206.
-
(1998)
Eur. J. Pharmacol.
, vol.353
, pp. 191-206
-
-
Klitgaard, H.1
Matagne, A.2
Gobert, J.3
Wulfert, E.4
-
185
-
-
0034864144
-
Levetiracetam: The preclinical profile of a new class of antiepileptic drugs?
-
Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 2001;42(Suppl 4):13-18.
-
(2001)
Epilepsia
, vol.42
, Issue.SUPPL. 4
, pp. 13-18
-
-
Klitgaard, H.1
-
186
-
-
0031908063
-
Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
-
Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.284
, pp. 474-479
-
-
Loscher, W.1
Honack, D.2
Rundfeldt, C.3
-
187
-
-
0034530035
-
Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam
-
Loscher W, Honack D. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam. Epilepsia 2000;41:1499-1506.
-
(2000)
Epilepsia
, vol.41
, pp. 1499-1506
-
-
Loscher, W.1
Honack, D.2
-
188
-
-
0030574062
-
The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata
-
Loscher W, Honack D, Bloms-Funke P. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata. Brain Res 1996;735:208-216.
-
(1996)
Brain Res.
, vol.735
, pp. 208-216
-
-
Loscher, W.1
Honack, D.2
Bloms-Funke, P.3
-
189
-
-
0036193683
-
Selective blockade of N-type calcium channels by levetiracetam
-
Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 2002;43:9-18.
-
(2002)
Epilepsia
, vol.43
, pp. 9-18
-
-
Lukyanetz, E.A.1
Shkryl, V.M.2
Kostyuk, P.G.3
-
190
-
-
0033811027
-
Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures
-
European Levetiracetam Study Group
-
Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 2000;41:1179-1186.
-
(2000)
Epilepsia
, vol.41
, pp. 1179-1186
-
-
Shorvon, S.D.1
Lowenthal, A.2
Janz, D.3
Bielen, E.4
Loiseau, P.5
-
191
-
-
0033775210
-
Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy
-
European Levetiracetam Study Group
-
Ben Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 2000;41:1276-1283.
-
(2000)
Epilepsia
, vol.41
, pp. 1276-1283
-
-
Ben Menachem, E.1
Falter, U.2
-
192
-
-
0033854805
-
Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
-
Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000;55:236-242.
-
(2000)
Neurology
, vol.55
, pp. 236-242
-
-
Cereghino, J.J.1
Biton, V.2
Abou-Khalil, B.3
Dreifuss, F.4
Gauer, L.J.5
Leppik, I.6
-
194
-
-
0004118573
-
A remarkable medicine has been overlooked
-
New York: Simon and Schuster
-
Dreyfus J. A remarkable medicine has been overlooked. New York: Simon and Schuster, 1981.
-
(1981)
-
-
Dreyfus, J.1
-
196
-
-
23544448881
-
Prophylactic effects of phenytoin in bipolar illness: A controlled study
-
Levine J, Bersudsky Y, Mishory A, Winokur M, Belmaker RH. Prophylactic effects of phenytoin in bipolar illness: a controlled study. Int J Neuropsychopharmacol 2002;5:S56-S57.
-
(2002)
Int. J. Neuropsychopharmacol.
, vol.5
-
-
Levine, J.1
Bersudsky, Y.2
Mishory, A.3
Winokur, M.4
Belmaker, R.H.5
-
197
-
-
0025994133
-
Antiepileptic drugs in affective illness: Clinical and theoretical implications
-
Smith DB, Treiman DM, Trimble MR, editors. New York: Raven
-
Post RM, Altshuler LL, Ketter TA, Denicoff K, Weiss SRB. Antiepileptic drugs in affective illness: Clinical and theoretical implications. In: Smith DB, Treiman DM, Trimble MR, editors. Neurobehavioral problems in epilepsy, Advances in neurology, vol. 55. New York: Raven, 1991. pp. 239-277.
-
(1991)
Neurobehavioral Problems in Epilepsy, Advances in Neurology
, vol.55
, pp. 239-277
-
-
Post, R.M.1
Altshuler, L.L.2
Ketter, T.A.3
Denicoff, K.4
Weiss, S.R.B.5
-
198
-
-
0021593902
-
Selective response to the anticonvulsant carbamazepine in manic-depressive illness: A case study
-
Post RM, Berrettini WH, Uhde TW, Kellner CH. Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study. J Clin Psychopharmacol 1984;4:178-185.
-
(1984)
J. Clin. Psychopharmacol.
, vol.4
, pp. 178-185
-
-
Post, R.M.1
Berrettini, W.H.2
Uhde, T.W.3
Kellner, C.H.4
-
199
-
-
0032837029
-
The use of primidone in the treatment of refractory bipolar disorder
-
Schaffer LC, Schaffer CB, Caretto J. The use of primidone in the treatment of refractory bipolar disorder. Ann Clin Psychiatry 1999;11:61-66.
-
(1999)
Ann. Clin. Psychiatry
, vol.11
, pp. 61-66
-
-
Schaffer, L.C.1
Schaffer, C.B.2
Caretto, J.3
-
200
-
-
0027229938
-
Barbiturate anticonvulsants in refractory affective disorders
-
Hayes SG. Barbiturate anticonvulsants in refractory affective disorders. Ann Clin Psychiatry 1993;5:35-44.
-
(1993)
Ann. Clin. Psychiatry
, vol.5
, pp. 35-44
-
-
Hayes, S.G.1
-
201
-
-
0021670332
-
Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis
-
Inoue H, Hazama H, Hamazoe K, et al. Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis. Folia Psychiatr Neurol Jpn 1984;38:425-436.
-
(1984)
Folia Psychiatr. Neurol. Jpn.
, vol.38
, pp. 425-436
-
-
Inoue, H.1
Hazama, H.2
Hamazoe, K.3
-
202
-
-
0032171374
-
Beyond lithium in the treatment of bipolar illness
-
Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1998;19:206-219.
-
(1998)
Neuropsychopharmacology
, vol.19
, pp. 206-219
-
-
Post, R.M.1
Frye, M.A.2
Denicoff, K.D.3
Leverich, G.S.4
Kimbrell, T.A.5
Dunn, R.T.6
-
203
-
-
0025234763
-
Adjunctive clonazepam for maintenance treatment of bipolar affective disorder
-
Sachs GS, Rosenbaum JF, Jones L. Adjunctive clonazepam for maintenance treatment of bipolar affective disorder. J Clin Psychopharmacol 1990;10:42-47.
-
(1990)
J. Clin. Psychopharmacol.
, vol.10
, pp. 42-47
-
-
Sachs, G.S.1
Rosenbaum, J.F.2
Jones, L.3
-
205
-
-
0033984510
-
Vagus nerve stimulation: A new tool for brain research and therapy
-
George MS, Sackeim HA, Rush AJ, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry 2000;47:287-295.
-
(2000)
Biol. Psychiatry
, vol.47
, pp. 287-295
-
-
George, M.S.1
Sackeim, H.A.2
Rush, A.J.3
-
206
-
-
0033961645
-
Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study
-
Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000;47:276-286.
-
(2000)
Biol. Psychiatry
, vol.47
, pp. 276-286
-
-
Rush, A.J.1
George, M.S.2
Sackeim, H.A.3
-
207
-
-
0037084471
-
Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes
-
Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002;51:280-287.
-
(2002)
Biol. Psychiatry
, vol.51
, pp. 280-287
-
-
Marangell, L.B.1
Rush, A.J.2
George, M.S.3
-
208
-
-
0034784012
-
Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome
-
Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001;25:713-728.
-
(2001)
Neuropsychopharmacology
, vol.25
, pp. 713-728
-
-
Sackeim, H.A.1
Rush, A.J.2
George, M.S.3
-
209
-
-
0025313979
-
Open trial of a calcium antagonist, nimodipine, in acute mania
-
Brunet G, Cerlich B, Robert P, Dumas S, Souetre E, Darcourt G. Open trial of a calcium antagonist, nimodipine, in acute mania. Clin Neuropharmacol 1990;13:224-228.
-
(1990)
Clin. Neuropharmacol.
, vol.13
, pp. 224-228
-
-
Brunet, G.1
Cerlich, B.2
Robert, P.3
Dumas, S.4
Souetre, E.5
Darcourt, G.6
-
210
-
-
0000459326
-
Clinical studies on nimodipine in the treatment of patients with depressive syndromes in the second half of life
-
Betz E, Deck K, Hoffmeister F, editors. Stuttgart: Schattauer
-
Eckmann F. Clinical studies on nimodipine in the treatment of patients with depressive syndromes in the second half of life. In: Betz E, Deck K, Hoffmeister F, editors. Nimodipine: pharmacological and clinical studies, Stuttgart: Schattauer, 1985. pp. 307-313.
-
(1985)
Nimodipine: Pharmacological and Clinical Studies
, pp. 307-313
-
-
Eckmann, F.1
-
211
-
-
0026320723
-
Disturbi affettivi bipolari e ruolo del calcio intraneuronale. Effetti terapeutici del trattamento con sali di litio e/o calcio antagonista in pazienti con rapida inversione di polarita
-
Manna V. Disturbi affettivi bipolari e ruolo del calcio intraneuronale. Effetti terapeutici del trattamento con sali di litio e/o calcio antagonista in pazienti con rapida inversione di polarita [Bipolar affective disorders and role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and/or calcium antagonist in patients with rapid polar inversion]. Minerva Med 1991;82:757-763.
-
(1991)
Minerva Med.
, vol.82
, pp. 757-763
-
-
Manna, V.1
-
212
-
-
0030050982
-
Ultra-rapid and ultradian cycling in bipolar affective illness
-
Kramlinger KG, Post RM. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996;168:314-323.
-
(1996)
Br. J. Psychiatry
, vol.168
, pp. 314-323
-
-
Kramlinger, K.G.1
Post, R.M.2
-
213
-
-
0025166101
-
Calcium receptor antagonists modify cocaine effects in the central nervous system differently
-
Pani L, Kuzmin A, Diana M, De Montis G, Gessa GL, Rossetti ZL. Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol 1990;190:217-221.
-
(1990)
Eur. J. Pharmacol.
, vol.190
, pp. 217-221
-
-
Pani, L.1
Kuzmin, A.2
Diana, M.3
De Montis, G.4
Gessa, G.L.5
Rossetti, Z.L.6
-
214
-
-
0025145464
-
Dihydropyridine calcium antagonists prevent cocaine-, but not amphetamine-, induced dopamine release and motor activity in rats
-
Rossetti ZL, Pani L, Kuzmin A, Carboni S, Gessa GL. Dihydropyridine calcium antagonists prevent cocaine-, but not amphetamine-, induced dopamine release and motor activity in rats. Acta Physiol Hung 1990;75:249-250.
-
(1990)
Acta Physiol. Hung
, vol.75
, pp. 249-250
-
-
Rossetti, Z.L.1
Pani, L.2
Kuzmin, A.3
Carboni, S.4
Gessa, G.L.5
-
215
-
-
0032509704
-
Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model
-
Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998;341:145-152.
-
(1998)
Eur. J. Pharmacol.
, vol.341
, pp. 145-152
-
-
Voskuyl, R.A.1
Vreugdenhil, M.2
Kang, J.X.3
Leaf, A.4
-
216
-
-
0032725468
-
The antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids
-
Leaf A, Kang JX, Xiao YF, Billman GE, Voskuyl RA. The antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids. J Membr Biol 1999;172:1-11.
-
(1999)
J. Membr. Biol.
, vol.172
, pp. 1-11
-
-
Leaf, A.1
Kang, J.X.2
Xiao, Y.F.3
Billman, G.E.4
Voskuyl, R.A.5
-
217
-
-
0036200360
-
Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients
-
Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002;43:103-104.
-
(2002)
Epilepsia
, vol.43
, pp. 103-104
-
-
Schlanger, S.1
Shinitzky, M.2
Yam, D.3
-
218
-
-
0032909325
-
Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial
-
Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-412.
-
(1999)
Arch. Gen. Psychiatry
, vol.56
, pp. 407-412
-
-
Stoll, A.L.1
Severus, W.E.2
Freeman, M.P.3
-
219
-
-
0036190807
-
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder
-
Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002;159:477-479.
-
(2002)
Am. J. Psychiatry
, vol.159
, pp. 477-479
-
-
Nemets, B.1
Stahl, Z.2
Belmaker, R.H.3
-
220
-
-
0036790628
-
A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
-
Peet M, Horrobin DF. A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002;59.
-
(2002)
Arch. Gen. Psychiatry
, pp. 59
-
-
Peet, M.1
Horrobin, D.F.2
-
221
-
-
0035089629
-
Convulsive therapy: A review of the first 55 years
-
Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord 2001;63:1-15.
-
(2001)
J. Affect. Disord.
, vol.63
, pp. 1-15
-
-
Fink, M.1
-
222
-
-
0028047366
-
Electroconvulsive therapy of acute manic episodes: A review of 50 years' experience
-
Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994;151:169-176.
-
(1994)
Am. J. Psychiatry
, vol.151
, pp. 169-176
-
-
Mukherjee, S.1
Sackeim, H.A.2
Schnur, D.B.3
-
223
-
-
0028019235
-
Maintenance ECT in intractable manic-depressive disorders
-
Vanelle JM, Loo H, Galinowski A, et al. Maintenance ECT in intractable manic-depressive disorders. Conv Ther 1994;10:195-205.
-
(1994)
Conv. Ther.
, vol.10
, pp. 195-205
-
-
Vanelle, J.M.1
Loo, H.2
Galinowski, A.3
-
224
-
-
0034199344
-
Combined ECT and clozapine in treatment-resistant mania
-
Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT 2000;16:204-207.
-
(2000)
J. ECT
, vol.16
, pp. 204-207
-
-
Chanpattana, W.1
-
225
-
-
0031805658
-
Cost reduction with maintenance ECT in refractory bipolar disorder
-
Bonds C, Frye MA, Coudreaut MF, et al. Cost reduction with maintenance ECT in refractory bipolar disorder. J ECT 1998;14:36-41.
-
(1998)
J. ECT
, vol.14
, pp. 36-41
-
-
Bonds, C.1
Frye, M.A.2
Coudreaut, M.F.3
-
226
-
-
0033431865
-
Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism
-
Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999;46:1603-1613.
-
(1999)
Biol. Psychiatry
, vol.46
, pp. 1603-1613
-
-
Kimbrell, T.A.1
Little, J.T.2
Dunn, R.T.3
-
227
-
-
0034672231
-
Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients
-
Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 2000;48:1133-1141.
-
(2000)
Biol. Psychiatry
, vol.48
, pp. 1133-1141
-
-
Speer, A.M.1
Kimbrell, T.A.2
Wassermann, E.M.3
-
229
-
-
0033931360
-
Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode
-
Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000;3:129-134.
-
(2000)
Int. J. Neuropsychopharmacol.
, vol.3
, pp. 129-134
-
-
Pridmore, S.1
Bruno, R.2
Turnier-Shea, Y.3
Reid, P.4
Rybak, M.5
-
230
-
-
0033964404
-
Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: An open study
-
Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000;47:314-324.
-
(2000)
Biol. Psychiatry
, vol.47
, pp. 314-324
-
-
Grunhaus, L.1
Dannon, P.N.2
Schreiber, S.3
-
231
-
-
0037090395
-
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: Preliminary results of a randomized trial
-
Janicak PG, Dowd SM, Martis B, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry 2002;51:659-667.
-
(2002)
Biol. Psychiatry
, vol.51
, pp. 659-667
-
-
Janicak, P.G.1
Dowd, S.M.2
Martis, B.3
-
232
-
-
0033977080
-
The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study
-
Frye MA, Ketter TA, Leverich GS, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000;61:9-15.
-
(2000)
J. Clin. Psychiatry
, vol.61
, pp. 9-15
-
-
Frye, M.A.1
Ketter, T.A.2
Leverich, G.S.3
-
233
-
-
0035146920
-
The star systems - Overview and use in determining antiepileptic drug choice
-
Brodie MJ, Kwan P. The star systems - overview and use in determining antiepileptic drug choice. CNS Drugs 2001;15:1-12.
-
(2001)
CNS Drugs
, vol.15
, pp. 1-12
-
-
Brodie, M.J.1
Kwan, P.2
-
234
-
-
0038604854
-
Morbidity in 258 bipolar outpatients followed for one year with daily prospective ratings on the NIMH-LCM
-
(in press)
-
Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes PM, et al. Morbidity in 258 bipolar outpatients followed for one year with daily prospective ratings on the NIMH-LCM. J Clin Psychiatry 2002;(in press).
-
(2002)
J. Clin. Psychiatry
-
-
Post, R.M.1
Denicoff, K.D.2
Leverich, G.S.3
Altshuler, L.L.4
Frye, M.A.5
Suppes, P.M.6
-
235
-
-
0035826424
-
Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder
-
Ftouhi-Paquin N, Alda M, Grof P, Chretien N, Rouleau G, Turecki G. Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder. Am J Med Genet 2001;105:301-305.
-
(2001)
Am. J. Med. Genet.
, vol.105
, pp. 301-305
-
-
Ftouhi-Paquin, N.1
Alda, M.2
Grof, P.3
Chretien, N.4
Rouleau, G.5
Turecki, G.6
-
236
-
-
0033810469
-
Single nucleotide polymorphisms and the future of genetic epidemiology
-
Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000;58:250-264.
-
(2000)
Clin. Genet.
, vol.58
, pp. 250-264
-
-
Schork, N.J.1
Fallin, D.2
Lanchbury, J.S.3
-
237
-
-
0032453717
-
Topographic EEG studies of mania
-
Small JG, Milstein V, Malloy FW, Klapper MH, Golay SJ, Medlock CE. Topographic EEG studies of mania. Clin Electroencephalogr 1998;29:59-66.
-
(1998)
Clin. Electroencephalogr.
, vol.29
, pp. 59-66
-
-
Small, J.G.1
Milstein, V.2
Malloy, F.W.3
Klapper, M.H.4
Golay, S.J.5
Medlock, C.E.6
-
238
-
-
0033652575
-
Lithium-induced EEG changes in patients with affective disorders
-
Schulz C, Mavrogiorgou P, Schroter A, Hegerl U, Juckel G. Lithium-induced EEG changes in patients with affective disorders. Neuropsychobiology 2000;42(Suppl 1):33-37.
-
(2000)
Neuropsychobiology
, vol.42
, Issue.SUPPL. 1
, pp. 33-37
-
-
Schulz, C.1
Mavrogiorgou, P.2
Schroter, A.3
Hegerl, U.4
Juckel, G.5
-
239
-
-
0028127340
-
Seizures in two patients after the addition of lithium to a clozapine regimen
-
[letter]
-
Garcia G, Crismon ML, Dorson PG. Seizures in two patients after the addition of lithium to a clozapine regimen [letter]. J Clin Psychopharmacol 1994;14:426-428.
-
(1994)
J. Clin. Psychopharmacol.
, vol.14
, pp. 426-428
-
-
Garcia, G.1
Crismon, M.L.2
Dorson, P.G.3
-
240
-
-
0033595496
-
Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders
-
Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53:S53-S67.
-
(1999)
Neurology
, vol.53
-
-
Ketter, T.A.1
Post, R.M.2
Theodore, W.H.3
|